New Langer startup to develop oral insulin
Prolific MIT life sciences inventor Robert Langer is behind a new startup backed by Boston-based drug developer Enlight BioSciences. Entrega Inc. will work to develop oral drug delivery technology for biologic drugs, including insulin and antibodies, which are used to treat diabetes, cancer and inflammatory disease.
Enlight launched in July 2008 out of Boston venture firm PureTech Ventures, where Langer is a founding senior partner. The Boston-based startup has strategic partnerships with drug giants Eli Lilly & Co., Johnson & Johnson, Merck & Co. Inc. and Pfizer Inc., worth $52 million.